Yayınlar & Eserler

Yayın Ağı
Makaleler 13
Tümü (13)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (13)
ESCI (2)
Scopus (11)
TRDizin (6)

1. [P323L Mutation in a Case with Prolonged SARS-CoV-2 PCR Positivity].

Yücebağ E., Arslan N., Tok Y., Nohut O. K., Salman Yılmaz S., Kuşkucu M. A., et al.
Mikrobiyoloji bulteni , cilt.57, sa.3, ss.490-497, 2023 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

2. One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test.

Tuyji Tok Y., Can Sarinoglu R., Ordekci S., Yilmaz S., Ozcolpan G., Bayram A., et al.
Vaccines , cilt.11, sa.2, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

3. Real-life experience: sensitivity and specificity of nasal and saliva samples for COVID-19 diagnosis

Yilmaz S., KUŞKUCU M. A., SARİBAL D., TOK Y., Ozdemir Y., ALKAN S., et al.
IRISH JOURNAL OF MEDICAL SCIENCE , cilt.191, sa.5, ss.2201-2206, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet's syndrome.

Ozdede A., Nohut O. K., Atli Z., Tok Y., Guner S., Yilmaz E., et al.
Rheumatology international , cilt.42, sa.10, ss.1741-1750, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

5. Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5

Tuyji-Tok Y., Yücebag E., Betül Keles A., Ceylan Kılınçarslan A., Nohut O. K., Salman-Yılmaz S., et al.
Infectious diseases and clinical microbiology (Online) , cilt.4, sa.3, ss.192-198, 2022 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

6. Detection of SARS-CoV-2 RNA in Upper Respiratory Swap Samples by Pooling Method.

Tok Y., Kuşkucu M. A., Erdem H., Sarıbal D., Salman Yılmaz S., Nohut O. K., et al.
Balkan medical journal , cilt.39, sa.1, ss.48-54, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

7. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1

Gönen M. S., Alaylıoğlu M., Durcan E., Özdemir Y., Şahin S., Konukoğlu D., et al.
NUTRIENTS , sa.11, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

8. Periodic Evaluation of Anti-SARS-CoV-2 Antibody Levels and Determination of Surrogate Virus Neutralization in Healthcare Workers with COVID-19

Tuyji Tok Y., KUŞKUCU M. A., SARİBAL D., Salman Yilmaz S., NOHUT O. K., AYGÜN G., et al.
MIKROBIYOLOJI BULTENI , cilt.55, sa.4, ss.507-518, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier identifier

9. First Report of SARS-CoV-2 Gamma Variant in Turkey

Kuskucu M. A., Tok Y., Nohut O. K., Abullayeva Z., Yücebag E., Can F., et al.
Infectious Diseases and Clinical Microbiology , cilt.3, sa.2, ss.97-99, 2021 (ESCI, TRDizin) identifier identifier

10. Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study.

Esatoglu S. N., Akkoc-Mustafayev F. N., Ozguler Y., Ozbakır F., NOHUT O. K., Cevirgen D., et al.
Frontiers in immunology , cilt.11, ss.618973, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

11. Immunogenicity of infliximab among patients with Behcet's syndrome: a controlled study

Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus) identifier

12. Immunogenicity of Infliximab Among Patients with Behcet's Syndrome: A Controlled Study

Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

13. Investigation of Plasmid-Mediated Quinolone Resistance Determinants in Enterobacteriaceae: A Multicenter Study

Coban A. Y., Nohut O. K., Cayci Y. T., BAYRAMOĞLU G., Pirincciler M., Cetinkaya E., et al.
MIKROBIYOLOJI BULTENI , cilt.46, sa.3, ss.366-374, 2012 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 3

1. Effect of acid addition as a preservative on 24h urine sample catecholamines and their metabolites

Nohut O. K., Konukoğlu D.
2nd International Azerbaijan Laboratory Medicine Congress & Lab Expo (AZLTK & LAB EXPO 2024), Baku, Azerbaycan, 2 - 04 Mayıs 2024, ss.151, (Özet Bildiri)

2. IMMUNOGENICITY OF INFLIXIMAB AMONG PATIENTS WITH BEHCET'S SYNDROME: A CONTROLLED STUDY

Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.767, (Özet Bildiri) identifier

3. SAMSUN HIFZISSIHHA ENSTİTÜSÜ H1N1 PANDEMİ DENEYİMİ

Nohut O. K.
6. Ulusal Tanısal ve Moleküler Mikrobiyoloji Kongresi, Ankara, Türkiye, 15 - 19 Haziran 2010, ss.179, (Tam Metin Bildiri) Creative Commons License
Metrikler

Yayın

20

Yayın (WoS)

15

Yayın (Scopus)

12

Atıf (WoS)

82

H-İndeks (WoS)

4

Atıf (Scopus)

94

H-İndeks (Scopus)

5

Atıf (Scholar)

93

H-İndeks (Scholar)

3

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Sobiad)

1

H-İndeks (Sobiad)

1

Atıf (Diğer Toplam)

2

Proje

3

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları